Compare TLNC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLNC | VNDA |
|---|---|---|
| Founded | 2025 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.0M | 387.9M |
| IPO Year | N/A | 2005 |
| Metric | TLNC | VNDA |
|---|---|---|
| Price | $10.27 | $6.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $14.90 |
| AVG Volume (30 Days) | 21.5K | ★ 891.0K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $216,105,000.00 |
| Revenue This Year | N/A | $21.35 |
| Revenue Next Year | N/A | $37.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.72 |
| 52 Week Low | $9.94 | $4.14 |
| 52 Week High | $11.30 | $9.91 |
| Indicator | TLNC | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 43.91 |
| Support Level | $10.20 | $5.97 |
| Resistance Level | $11.30 | $6.73 |
| Average True Range (ATR) | 0.01 | 0.23 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 50.00 | 28.75 |
Talon Capital Corp is a newly organized blank check company.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.